These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 11122147)
1. Abnormalities of adherent layers grown from bone marrow of patients with myelodysplasia. Tennant GB; Walsh V; Truran LN; Edwards P; Mills KI; Burnett AK Br J Haematol; 2000 Dec; 111(3):853-62. PubMed ID: 11122147 [TBL] [Abstract][Full Text] [Related]
2. Blast colony forming cell-binding capacity of bone marrow stroma from myelodysplastic patients. Gidáli J; Fehér I; Hollán SR Stem Cells; 1996 Sep; 14(5):577-83. PubMed ID: 8888498 [TBL] [Abstract][Full Text] [Related]
3. The synergistic effect of thrombopoietin in erythropoiesis with erythropoietin and/or IL-3 and myelopoiesis with G-CSF or IL-3 from umbilical cord blood cells of full-term neonates. Liang DC; Shih LY; Kuo MC; Chai IJ; Su TH; Chen SH; Liu HC; Shimosaka A Pediatr Hematol Oncol; 2001 Sep; 18(6):383-91. PubMed ID: 11554233 [TBL] [Abstract][Full Text] [Related]
4. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro. Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784 [TBL] [Abstract][Full Text] [Related]
5. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome. Zheng Z; Qianqiao Z; Qi H; Feng X; Chunkang C; Xiao L Exp Hematol; 2010 Aug; 38(8):677-84. PubMed ID: 20394797 [TBL] [Abstract][Full Text] [Related]
7. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone. Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570 [TBL] [Abstract][Full Text] [Related]
8. Thrombopoietin and chemokine mRNA expression in patient post-chemotherapy and in vitro cytokine-treated marrow stromal cell layers. Schwartz GN; Kammula U; Warren MK; Park MK; Yan XY; Marincola FM; Gress RE Stem Cells; 2000; 18(5):331-42. PubMed ID: 11007917 [TBL] [Abstract][Full Text] [Related]
9. The detection of colony-stimulating factors and steel factor in adherent layers of human long-term marrow cultures using reverse-transcriptase polymerase chain reaction. Deschaseaux ML; Hervé P; Charbord P Leukemia; 1994 Mar; 8(3):513-9. PubMed ID: 7510357 [TBL] [Abstract][Full Text] [Related]
10. Measurement of mRNA expression for a variety of cytokines and its receptors in bone marrows of patients with myelodysplastic syndromes. Allampallam K; Shetty V; Hussaini S; Mazzoran L; Zorat F; Huang R; Raza A Anticancer Res; 1999; 19(6B):5323-8. PubMed ID: 10697556 [TBL] [Abstract][Full Text] [Related]
11. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes. Tauro S; Hepburn MD; Bowen DT; Pippard MJ Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409 [TBL] [Abstract][Full Text] [Related]
12. Nontransformed colony-derived stromal cell lines from normal human marrows. I. Growth requirement and myelopoiesis supportive ability. Sensebe L; Li J; Lilly M; Crittenden C; Herve P; Charbord P; Singer JW Exp Hematol; 1995 Jun; 23(6):507-13. PubMed ID: 7768306 [TBL] [Abstract][Full Text] [Related]
13. IL-1 inhibits B cell differentiation in long term bone marrow cultures. Dorshkind K J Immunol; 1988 Jul; 141(2):531-8. PubMed ID: 3260256 [TBL] [Abstract][Full Text] [Related]
14. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes. Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249 [TBL] [Abstract][Full Text] [Related]
15. In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor. Mayani H; Baines P; Bowen DT; Jacobs A Leukemia; 1989 Jan; 3(1):29-32. PubMed ID: 2642575 [TBL] [Abstract][Full Text] [Related]
16. Composition and functional integrity of the in vitro hemopoietic microenvironment in acute myelogenous leukemia: effect of macrophage colony-stimulating factor. Mayani H; Guilbert LJ; Clark SC; Belch AR; Janowska-Wieczorek A Exp Hematol; 1992 Oct; 20(9):1077-84. PubMed ID: 1468541 [TBL] [Abstract][Full Text] [Related]
17. Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells. Bendall LJ; Daniel A; Kortlepel K; Gottlieb DJ Exp Hematol; 1994 Dec; 22(13):1252-60. PubMed ID: 7957711 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms mediating the inhibitory effect of all-trans retinoic acid on primitive hematopoietic stem cells in human long-term bone marrow culture. Sammons J; Ahmed N; Khokher MA; Hassan HT Stem Cells; 2000; 18(3):214-9. PubMed ID: 10840075 [TBL] [Abstract][Full Text] [Related]
19. Leukaemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with myelodysplasia: a methodological approach under serum-free culture conditions. Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schmid C; Schweiger C; Kolb HJ; Schmetzer HM Scand J Immunol; 2005 Jul; 62(1):75-85. PubMed ID: 16091127 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the adherent cells developed in Dexter-type long-term cultures from human umbilical cord blood. Gutiérrez-Rodríguez M; Reyes-Maldonado E; Mayani H Stem Cells; 2000; 18(1):46-52. PubMed ID: 10661571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]